presentation ( format)

advertisement

Total Quality

Improvement Assessment

Of Strep C β-Hemolytic

Streptococci Treatment in a College Population

Valerie Kiefer MS, APRN

University Of Connecticut

The University of Connecticut provides primary health care to approximately

20,000 students annually.

24-Hour Care

Fee for Service

Departments:

◦ Primary Care

◦ Walk-In Clinic

◦ Women’s Clinic

◦ Allergy Clinic

◦ Counseling & Mental Health

◦ 9 Bed In-Patient

◦ Laboratory

◦ Radiology

◦ Pharmacy

What is Group C Streptococcus?

Gram positive anaerobe which produce small or large colonies

Usually beta hemolytic

Share many clinical characteristics with

GAS

Group C can cause isolated exudative or common source epidemic pharyngitis indistinguishable clinically from GAS

Large colony

Small colony are not associated with pharyngitis

Why Study Group C Strep?

Pharyngitis and Group C Streptococcus common in college health

Do You Treat or Test for Group C strep pharyngitis?

Unknown if the association of group C

(BHS) pharyngitis in college students is related to immunity issues, lifestyle or other factors

Review Of The Literature

Studies that have shown strong epidemiologic association between group-C BHS and endemic pharyngitis in college students

Review Of The Literature

Turner et al, JAMA 1990

Association of Group C β-Hemolytic

Streptococci With Endemic

Pharyngitis Among College Students

Purpose: NGA BHS could be detected more commonly in the throats of students with symptomatic pharyngitis than among healthy controls of similar age.

Performed throughout 2 school years

NGA BHS group, only those from group C were isolated more often/compared with the control group (26% to 11%)

Established a strong epidemiologic association between group C BHS and endemic pharyngitis in college students

Group C BHS had fever, exudative tonsillitis and anterior cervical adenopathy more frequently than patients who were negative for group C

Turner et al, Journal Of Clinical

Microbiology 1997

Epidemiologic Evidence From

Lancefield Group C Beta Hemolytic

Streptococci As A Cause Of Exudative

Pharyngitis In College Students

Compared the isolation rates of strains of group C BHS from throat swab cultures of patients with exudative pharyngitis, the common cold, and healthy controls

College health/chart review

Isolation of Lancefield group A and C beta-hemolytic streptococci from throat cultures was used as an outcome measurement

Lancefield Group C strep associated with purulent exudative pharyngitis in college students.

Broyles et al, Clinical Infectious

Disease 2009

Population-Based Study of Invasive

Disease Due to β-Hemolytic

Streptococci of Groups Other than A and B

Different Species of non A, non B – hemolytic streptococci and their clinical significance

NABS Comprise multiple distinct species that cause infections. (G,B,H)

Manifestations differ, specification may be warranted in clinical settings

Tiemstra et al, Journal American Board

Family Medicine 2009

Role of Non Group A Streptococci in

Acute Pharyngitis

The role of Non Group A strep as pathogens of pharyngitis is controversial.

Data is limited and conflicting on whether these bacteria are true pathogens of pharyngitis and whether treatment is indicated in all or just select cases.

Objective: Determine whether in non-GAS identified on culture if the clinical signs and symptoms resemble group

A  implicating them as true pathogens or if they resemble culture negative pharyngitis suggesting they are viral in etiology

Retrospective case control study

Mean age 26 years

GAS by RAS or culture

Neg. RSA or culture

Headache and fever associated strep infection, no difference between GAS and non GAS

Exudates and lymphadenopathy were also associated with both GAS and non GAS compared with viral infection

2 criteria were present, risk any strep infection rose to 55% (27% for non GAS or GAS)

3 or more criteria present, risk increased to 81% (non-GAS 34%, GAS 47%)

Results: Young, adult population with acute pharyngitis, non GAS was as common as GAS

Non GAS same clinical features typically associated with GAS

Suggests clinicians may want to consider treating patients with proven or presumptive non GAS pharyngitis who fail to respond to symptomatic therapy or who are at increased risk for sequelae

Further study needed/antibiotic treatment

Cooper et al, Annals Of Internal

Medicine 2001, Principles of

Appropriate Antibiotic Use For Acute

Pharyngitis In Adults, Position Paper

Examines the available evidence regarding the diagnosis and treatment of acute

GABHS in adult patients

Recommendations made that balance concerns about the potential consequences of untreated GABHS and the goal of decreasing inappropriate antibiotic prescriptions

Group A strep is the causal agent in 10% of adult cases of pharyngitis.

Antibiotics are prescribed to 75% of adult patients with acute pharyngitis.

Incidence of complications regardless of treatment with antibiotics is low.

Antibiotic therapy instituted within 2-3 days of symptom onset hastens symptomatic improvement by 1-2 days in patients/cultures grow GABHS.

Antibiotics do not have this effect with a negative culture.

Symptom duration is strongly related to patient satisfaction.

Antibiotic treatment benefits only those patients with GABHS.

Limit antibiotic prescriptions to patients who are most likely to have GABHS infections.

Rutecki, Top Papers Of The Month,

Does This Patient Have Group A Strep

Pharyngitis?, Consultant 2012

This paper discussed pharyngitis and the

Centor Criteria.

Include Centor Criteria in

Management/approach to pharyngitis.

Shah, Centor and Jennings,

Severe Acute Pharyngitis Caused by

Group C Streptococcus, 2006 Case

Report

Group C Strep. / Approx. 5% prevalence

Present Broad Spectrum of Severity

Less common cause of acute pharyngitis but has both similar microbiology and presentation to group A.

Both cause exudative or epidemic pharyngitis which are indistinguishable clinically.

5 Important Considerations/Neg.

RSA/ Worsening Symptoms

Mono

Acute HIV

Group C

Peritonsillar Abscess

Lemierre’s Syndrome

(Fusobacterium necrophorum)

Neg. RSA /possibly worsen over the next week

Reasons We Treat Strep Throat

Strep A causal agent 10%

Reduce Symptoms

Prevent the spread of Streptococci

Prevent Infectious Complications

◦ Tonsillar Abscesses

◦ Sinusitis

Prevent Rheumatic Fever /2011 incidence of rheumatic fever in the US was 1 per 1 million strep throats

Prevent Glomerulonephritis

Majority of adults have a self limited illness who do not need antibiotics

Group C Strep-

Does not cause some of the complications caused by Group A

Uncommon cause of pneumonia

Group C Strep sinusitis has been reported

Rarely isolated from blood cultures/fewer than 1% of all bacteremia

Group C and G Strep meningitis have

 been reported and are often associated with endocarditis

Group C Strep arthritis uncommon/occurs in joints with preexisting rheumatologic abnormalities

Role of Non-Group A Streptococci

Conflicting and limited data

◦ Guidelines/Standards treat Strep A

◦ Controversy regarding management strategy for adult pharyngitis

◦ Dr. Centor points out in the article: Pharyngitis

Management: Defining the Controversy

JGIM (2007)

◦ Randomized trial data suggests a symptomatic benefit for treating Group C patients

Infectious Diseases Society of America

(IDSA) 2012 Clinical Practice Guideline for the Diagnosis and Management of

Group A Streptococcal Pharyngitis

Group C Strep common cause of acute pharyngitis among college students and adults

Primary reason to identify GCS as the etiologic agent of acute pharyngitis is to initiate antibiotic therapy that may reduce the clinical impact of the illness

Currently, there is no convincing evidence from controlled studies of a clinical response to antibiotic therapy in patients with acute pharyngitis from GCS isolated from the throat

CDC recommends not treating GCS.

Community Vs. College Health

Rapid Strep A testing (RSA)

◦ Fever

◦ Exudative Tonsillitis

◦ Adenopathy

◦ No cough

◦ A back up throat culture is not routinely performed

◦ Community/Follow up visit

UCONN

RSA

Back Up Throat Culture

Treated by Clinical Presentation

RSA Neg.

 Strep C  No Improvement 

Antibiotic

Follow up visit or antibiotic left at clinic for pick up by student

Time period of antibiotic treatment could range from 1-5 days post visit

OSOM

RSA

Ultra Strep A Test

98.2% Sensitive

Single Swab Culture

Quality of the test depends on the quality of the sample. Negative results can occur from inadequate specimen collection

Does not differentiate between carriers and acute infection

Used as an adjunct to other information available to the provider

Purpose of Study/Quality Issues

Addressed

Quality Improvement Assessment

To determine if antibiotic use in the treatment of Group C BHS in the college population is appropriate in relationship to community standards/guidelines.

◦ College Population DIFFERENT!!

To evaluate if the University of Connecticut’s quality of care and guidelines are appropriate in the treatment of Group C BHS

To assess the time frame of treatment or non treatment of Group C BHS .

Same day treatment

Next day treatment

Treatment within 2-5 days of visit

To evaluate key indicators in relationship to

Group C BHS in the college population.

◦ Tonsillitis

◦ Mononucleosis

Collected data before & after an educational action for clinical staff

Performance Goals

Difficult to set/lack of guidelines

College Health taken into account

75% adult pharyngitis patients treated with an antibiotic

Performance Goals

70% Total Patients Treated with antibiotic

10% Patients Treated with antibiotic day 1

10% Patients Treated with antibiotic day 2- 5

Looked at:

Under and over usage of antibiotics

Quality of care and outcome issues as well as practice guidelines

Data Description

Retrospective Chart Audit January/11 to

March/11

786 Diagnosed With Pharyngitis

PeopleSoft#

Date of Examination

Positive for Group C BHS

Negative treatment with an antibiotic

Treated with an antibiotic/time frame

Tonsillitis or Mononucleosis

Follow up visit or phone call

Antibiotic Use

Before Corrective Action:

119 Positive Group C BHS

Patients diagnosed with

Strep C

Same Day

Treatment

Next Day

Treatment

Treatment in 2-5

Days

No Treatment

Cases of

Tonsillitis

January

Patients

13

3

3

6

3

February

Patients

March

Patients

Total

15

14

2

7

6

24

11

10

11

10

52

28

15

24

19

%

44%

23%

13%

20%

16%

Follow-Up Done

Before Corrective Action

Patients diagnosed with

Strep C

Follow-up

Phone Call

Follow-up Visit

January

Patients

February

Patients

March

Patients

Total

13

9

30

4

37

13

70

26

%

59%

22%

Follow-Up Done

Before Corrective Action

80

70

60

50

40

30

20

10

0

January

Patients

February

Patients

March

Patients

Total

Follow-up Phone Call

Follow-up Visit

Data Analysis

Before Corrective Action:

80% Treated with an antibiotic

44% Same Day

23% Next Day

13% Day 2-5

16% Tonsillitis

6% Mononucleosis

59% Follow-up Phone Call

22% Follow-up Visit

Antibiotics Used

Penicillin VK 500 mg TID

Zithromax (Z-Pak)

Amoxicillin 875 mg BID

Augmentin 875 mg-125 mg BID

Clindamycin 300 mg TID

Biaxin 500 mg BID

IDSA Recommendations

PCN 500 MG BID

AMOXICILLIN 50 MG/KG QD

(MAX = 1000 MG)

AZITHROMYCIN 12 MG/KG QD

(MAX = 500 MG)

Performance Goals Comparison

Goal: 70% Treated

Performance: 80% Treated

Goal: 10% Treated/Next Day

Performance: 24% Treated/Next Day

Goal: 10% Treated/Day 2-5

Performance: 13% Treated/Day 2-5

Discussion

Community Standards/College Health

Standards

Laboratory On Site/Depending on the time the student is seen, we will get a throat culture back the next day

2 Day Illness History/Average of 2 days of illness before they come in for an evaluation

Issues Of Concern

Antibiotic Offered Too Soon/Patient would have eventually improved and not needed to be treated with an antibiotic

80% Antibiotic Treatment for Strep C was too high in relation to community standards and we were prematurely over prescribing antibiotics

Laboratory Turnaround/Prompt turnaround of backup throat cultures contributed to our increased antibiotic usage. If the backup culture was returned 1 day post visit / probability of student still having a sore throat was high which in turn could influence the provider to prescribe an antibiotic

Issues Of Concern

Reevaluation Of Symptoms

Prescribing antibiotics without consistent reevaluation of patients was not appropriate medical care or follow up and addressed quality of care issues

Corrective Actions

Positive Group C BHS results would not be reported until 3 days post visit/Address the quick turnaround time of cultures from our laboratory

Laboratory results available if needed/provider call the lab for a result if there was a clinical concern

Provider would continue patient education/Issues or concerns call or make an appointment to be seen

Comfort Measures/Treatment for Sore Throat

Corrective Actions

Clinical Judgment/Same day treatment would not be addressed due to the involvement of the providers judgment regarding antibiotic usage

Group C BHS reported to clinician

Student with continued symptoms/ follow –up visit/antibiotic would not be left at the clinic or in the pharmacy

Original provider or back up clinician

Corrective Actions

Implemented

January 2012

Re-Measuring Of Data

Chart Audit

January 2012 to March 2012

107 Charts Audited

773 With Pharyngitis Diagnosed

Same Criteria

PeopleSoft #

Date Of Examination

Positive For Group C BHS

Negative Treatment With An Antibiotic

Treated With An Antibiotic

Time Frame of Treatment

Same Day, Next Day, Day 2-5

Tonsillitis or Mononucleosis Diagnosed

Follow Up Visit or Phone Call

Data Collection

After Corrective Actions:

107 Positive Group C BHS

Patients diagnosed with

Strep C

Same Day

Treatment

Next Day

Treatment

Treatment in 2-5

Days

No Treatment

Cases Tonsillitis

January

Patients

14

1

0

8

9

February

Patients

March

Patients

Total

25

0

5

21

10

14

2

3

14

10

53

3

18

43

29

%

50%

3%

7%

40%

27%

xxx

Antibiotic Use

After Corrective Action

60

50

40

30

20

10

0

January Patients February Patients March Patients Total

Same Day Treatment

Next Day Treatment

Treatment in 2-5 Days

No Treatment

Follow-Up Done

After Corrective Action

Patients diagnosed with

Strep C

Follow-up Phone

Call

Follow-up Visit

January

Patients

14

6

February

Patients

March

Patients

Total

25

15

22

4

61

25

%

57%

23%

70

60

50

40

30

20

10

0

January

Patients

Follow-Up Done

After Corrective Action

February

Patients

March Patients Total

Follow-up Phone Call

Follow-up Visit

Data Analysis

Initial

60% Treated With An Antibiotic (80%)

50% Treated The Same Day (44%)

3% Treated The Next Day (23%)

7% Treated Day 2-5 (13%)

27% Diagnosed With Tonsillitis (16%)

7% Diagnosed with Mononucleosis (6%)

57% Follow Up Phone Calls (59%)

23% Follow Up Visit (22%)

Data Before & After Corrective Action

%

Total Rx with Antibiotic

Treated Same Day

Treated Next Day

Treated Day 2-5

Dx as Tonsillitis

Dx as Mononucleosis

F/U Phone Call

F/U Visit

Before

Corrective

Action

80

44

23

13

16

6

59

22

After

Corrective

Action

60

50

27

7

57

23

3

7

Results

Overall Antibiotic Treatment Decreased

33%

Next Day Treatment Significantly Reduced

From 23% to 3%

Treatment From Day 2-5 Decreased 47%

Same Day Treatment Slightly Increased

From 44% to 50%

Tonsillitis Increased To 68%

Follow Up Phone Calls

Follow Up Visits Down 4%

Performance Goal Comparison

Goal: 70% Treated

Performance: 60% Treated

Goal: 10% Treated/Next Day

Performance 3% Treated/Next Day

Goal: 10% Treated/Day2-5

Performance 7% Treated/Day 2-5

Data Analysis

Improvement and Achievement of Our

Performance Goals

Decreased Antibiotic Usage

This affects antibiotic resistance and has a positive effect on health issues

Improved Quality Of Care

Providing follow up visits on students who were not improving. The only antibiotic provided to students post initial visit were given at the time of follow up office visits by providers

Limitations Of Assessment

Strep C Only/QI Assessment

College Health

Clinical Judgment

Tonsillitis and Mononucleosis

FUTURE STUDY

Comparing Group A Clinical Presentation to Group C Presentation

Centor Criteria

Predictive Method to Diagnosis Strep A

Relationship In Predicting Strep C

Centor Criteria

Set of 4 criteria which may be used to identify the likelihood of a Group A Strep infection in patients complaining of pharyngitis.

It is a method that can be used to quickly diagnosis the probability of Strep A.

Based On 4 Criteria

Fever ≥100.5

Absence Of Cough

Tonsillar Exudate

Tender Anterior Cervical Adenopathy

Centor Criteria

Score 0-1: less than 10% Probability

Not worthwhile to test.

Score 2-3: Intermediate Probability

Score of 2, 15% Prob.

Score of 3, 32% Prob.

RSA test done.

You can follow with a throat cx.

Score 4: 60% Probability

Consider empiric antibiotic Rx.

Some perform a RSA.

Presence of all 4 criteria: 40-60% prob. of GAS present

Absence of all 4 criteria: negative predictive value of greater than 80% GAS not present

High predictive value – Better at ruling out rather than ruling in strep throat.

Centor Criteria/application to testing on students with pharyngitis and Group C

BHS

Pharyngitis/ Centor Criteria EHR

Implementation of guidelines for treatment of Group C BHS in the college population

Throat Facts

8/1/12-5/15/13

Point Of Care

1,425

Rapid Strep In Lab

53

Back Up Throat Cultures In Lab

401

Download